Synapsys
CVE-2022-30277
MEDIUM
Severity by source
AV:P/AC:L/PR:L/UI:R/S:U/C:H/I:H/A:N
Primary rating from NVD · only source for this CVE.
CVSS VectorNVD
CVSS:3.1/AV:P/AC:L/PR:L/UI:R/S:U/C:H/I:H/A:N
Lifecycle Timeline
1DescriptionNVD
BD Synapsys™, versions 4.20, 4.20 SR1, and 4.30, contain an insufficient session expiration vulnerability. If exploited, threat actors may be able to access, modify or delete sensitive information, including electronic protected health information (ePHI), protected health information (PHI) and personally identifiable information (PII).
AnalysisAI
BD Synapsys™, versions 4.20, 4.20 SR1, and 4.30, contain an insufficient session expiration vulnerability. Rated medium severity (CVSS 5.7), this vulnerability is low attack complexity. No vendor patch available.
Technical ContextAI
This vulnerability is classified under CWE-613. BD Synapsys™, versions 4.20, 4.20 SR1, and 4.30, contain an insufficient session expiration vulnerability. If exploited, threat actors may be able to access, modify or delete sensitive information, including electronic protected health information (ePHI), protected health information (PHI) and personally identifiable information (PII). Affected products include: Bd Synapsys.
RemediationAI
No vendor patch is available at time of analysis. Monitor vendor advisories for updates. Apply vendor patches when available. Implement network segmentation and monitoring as interim mitigations.
Same weakness CWE-613 – Insufficient Session Expiration
View allSame technique Information Disclosure
View allShare
External POC / Exploit Code
Leaving vuln.today